Recent analysts Ratings: Mead Johnson Nutrition Company (NYSE:MJN)
- Author: Zachary Reyes Feb 14, 2017,
Feb 14, 2017, 4:44
The company also forecast 2017 sales growth below some analyst estimates, citing the ongoing impact of those issues and a challenging macroeconomic backdrop.
Ralph Lauren Corporation (NYSE:RL) [Trend Analysis] shows fluctuation in active trade, on Monday shares surged 2.09% to $79.61. The firm had revenue of $901.60 million for the quarter, compared to analyst estimates of $928.84 million.
Mead Johnson Nutrition Company (NYSE:MJN) [Trend Analysis] tries to capture market sentiments, shares rose 5.62% to $87.72. At present, 9 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. It turned higher 19.68% from its 50-day simple moving average. The company operates through two segments, Activision Publishing, Inc. and Blizzard Entertainment, Inc. Similarly, the company has Return on Assets of 6.2 percent, Return on Equity of 12.3 percent and Return on Investment of 9 Percent. The company's net profit margin has achieved the current level of 16.2 percent and possesses 63.7 percent gross margin. Activision Blizzard, Inc.is headquartered in Santa Monica, California. Now the stock is holding a "Buy" rating from 1 equity analysts.
Our vendor, Zacks Investment Research, hasn't provided us with the upcoming earnings report date.
Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. Reckitt Benckiser (RB) agreed to buy USA baby formula maker Mead Johnson Nutrition (MJN) for $16.6 billion, giving the British consumer goods company a new product line and expanding its presence in developing markets. The company's mission is to nourish the world's children for the best start in life. Ropes Wealth Advisors LLC bought a new stake in Mead Johnson Nutrition Company during the second quarter worth approximately $310,000. The companys Enfa family of brands, including Enfamil? infant formula, is the worlds leading brand franchise in pediatric nutrition. Mead Johnson Nutrition Company has a one year low of $69.25 and a one year high of $94.40. Finance believes the true inherent value of the stock could be as high as $95.00. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell). The stock has a market cap of $16.27 billion, a price-to-earnings ratio of 30.21 and a beta of 1.38. The Company Touched its 52-Week High on Jul 26, 2016 and 52-Week Low on Feb 1, 2017. Stock exchanged hands with the total volume of 2.81 Million shares, as contrast to its average volume of 2.02 Million shares.
MEAD JOHNSON NUTRITION COMPANY (MJN) has received mean Analyst rating of 2.50 from polled analysts at Reuters One Month Ago. This shows a surprise factor of -3.7 percent. Inside the closing six months period the stock's performance declined -0.09% while overall yearly performance gained 29.48%. However brokerage recommendations suggests an ABR of 2.50 based on calls of 8 experts, where 2 brokers polls the stock a Strong Buy, 0 suggest the stock a Buy, 6 suggest Hold, 0 are rating the stock as Sell while 0 as Strong Sell. As of December 31, 2015, its consolidated recoverable proven and probable mineral reserves included 99.5 billion pounds of copper, 27.1 million ounces of gold, 3.05 billion pounds of molybdenum, 271.2 million ounces of silver, and 0.87 billion pounds of cobalt; and its estimated proved oil and natural gas reserves totaled 252 million barrels of oil equivalents. The company has Weekly Volatility of 1.19%% and Monthly Volatility of 2.20%%. Susquehanna Bancshares Inc reiterated a "hold" rating and issued a $90.00 price objective on shares of Mead Johnson Nutrition Company in a report on Wednesday, October 19th.
The Company now has ROA (Return on Assets) of 13.3 percent, Return on Equity (ROE) of -99.3 Percent and Return on Investment (ROI) of 0% with Gross margin of 64.2 percent and Operating & Profit margin of 0% and 14.5% respectively.